Loading clinical trials...

Impact of Acquired FXIII Deficiency on Morbidity and Mortality | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04416594

Impact of Acquired FXIII Deficiency on Morbidity and Mortality

Observational prospective study aiming to assess acquired FXIII deficiency implications in morbidity and mortality

Lead sponsor: Patricia Duque González•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment50

Start dateSep 2019

Last updatedJun 5, 2020

Condition

Acquired Factor XIII Deficiency Disease

Locations shown

Gregorio Marañon Hospital

Madrid

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 5, 2020Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions